Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06332950
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-27
First Post:
2024-03-20
Brief Title:
Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome II With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
Sponsor:
Baohui Han
Organization:
Shanghai Chest Hospital
Organization Data
Organization:
Shanghai Chest Hospital
Class:
OTHER
Study ID:
MA-SCLC-II-015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baohui Han
Lead Sponsor Class:
OTHER
Responsible Party:
Baohui Han
Responsible Party Title:
Chief physician
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Chest Hospital
Old Name:
None
Old Organization:
None